Investor and advisor in strategy, innovation management, and commercialization, focused on life sciences tools and services.
An entrepreneurial and strategic international business leader, Phil joined Gamma Biosciences in 2020 from Cytiva’s Cell and Gene Therapy business. At Gamma, Phil is responsible for technical diligence, as well as guiding operational, R&D and strategic initiatives carried out at portfolio companies. Phil received his Ph.D. in Biochemistry and Molecular Biology at Georgetown University Medical Center, with research focused in molecular oncology. Subsequently, Phil completed his postdoctoral training in Molecular Oncology under an IRTA fellowship at the National Cancer Institute in Maryland. Phil was an instructor at Johns Hopkins University’s Biotechnology Marketing in the Masters of Biotechnology / MBA program, and has held strategy and innovation leadership positions in a number of life sciences companies including Life Technologies, Becton Dickinson, and Lonza. Phil is a board Member of CCRM Enterprises in Toronto Canada and a Board Member of the Foundation for Cell and Gene Medicine. Additionally, Phil is a mentor for the Creative Destruction Lab (CDL) entrepreneurship program, and an advisor to several life sciences companies. Phil has served as board member and executive commitee member of the Alliance for Regenerative Medicine (ARM), sits on ISCT’s technology and investment committees, ESP mentoring program, and has been a contributing organizer of ISCT annual meetings.
An entrepreneurial and strategic international business leader, Phil joined Gamma Biosciences in 2020 from Cytiva’s Cell and Gene Therapy business. At Gamma, Phil is responsible for technical diligence, as well as guiding operational, R&D and strategic initiatives carried out at portfolio companies. Phil received his Ph.D. in Biochemistry and Molecular Biology at Georgetown University Medical Center, with research focused in molecular oncology. Subsequently, Phil completed his postdoctoral training in Molecular Oncology under an IRTA fellowship at the National Cancer Institute in Maryland. Phil was an instructor at Johns Hopkins University’s Biotechnology Marketing in the Masters of Biotechnology / MBA program, and has held strategy and innovation leadership positions in a number of life sciences companies including Life Technologies, Becton Dickinson, and Lonza. Phil is a board Member of CCRM Enterprises in Toronto Canada and a Board Member of the Foundation for Cell and Gene Medicine. Additionally, Phil is a mentor for the Creative Destruction Lab (CDL) entrepreneurship program, and an advisor to several life sciences companies. Phil has served as board member and executive commitee member of the Alliance for Regenerative Medicine (ARM), sits on ISCT’s technology and investment committees, ESP mentoring program, and has been a contributing organizer of ISCT annual meetings.